跳至主要内容
临床试验/NCT01574261
NCT01574261Unknown早期 1 期

Could the Therapy With Inositol Affect the Cardiovascular Risk in PCOS Women? Results of a Randomized Clinical Trial

Catholic University of the Sacred Heart1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2012年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
入组人数
70
试验地点
1
主要终点
CD4+ CD28 null T-lymphocyte frequency

研究概览

简要总结

Polycystic ovary syndrome (PCOS) is associated with an increased cardiovascular risk. The aim of the study was to evaluate long-term effects of inositol on some cardiovascular risk factors in PCOS patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Polycystic Ovary Syndrome
  • Age >18 and <35

排除标准

  • Chronic or acute inflammatory disease, cancer, autoimmune disease, treatment during the last 6 months prior to our evaluation, DM2, hypertension, major surgery in the last 3 months or other hormonal dysfunctions (hypothalamic, pituitary, thyroidal, or adrenal causes).

研究组 & 干预措施

Inositol

Active Comparator

Patients will be randomized to receive Inositol 4 g/die per os for four months of treatment

干预措施: Inositol (Drug)

Placebo

Placebo Comparator

Patients will be randomized to receive placebo for four months

干预措施: Placebo (Drug)

结局指标

主要结局

CD4+ CD28 null T-lymphocyte frequency

时间窗: five minutes

次要结局

  • insulinaemic area OGTT AUCi, lipid profile, androgen levels(120 minutes)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Rosanna Apa

Professor

Catholic University of the Sacred Heart

研究点 (1)

Loading locations...

相似试验